Skip to main content

Articles

Page 60 of 71

  1. Radiotherapy (RT) and androgen-deprivation therapy (ADT) are standard treatments for advanced prostate cancer (PC). Tumor vascularization is recognized as an important physiological feature likely to impact on...

    Authors: Kathrine Røe, Lars TG Mikalsen, Albert J van der Kogel, Johan Bussink, Heidi Lyng, Anne H Ree, Laure Marignol and Dag R Olsen
    Citation: Radiation Oncology 2012 7:75
  2. Local control rates are poor in the treatment of pancreatic cancer. We investigated the role of hypofractionated stereotactic body radiation therapy (SBRT) for salvage or boost treatment after conventional dos...

    Authors: Chris E Lominska, Keith Unger, Nadim M Nasr, Nadim Haddad and Greg Gagnon
    Citation: Radiation Oncology 2012 7:74
  3. The primary objective of this research was to assess the relationship between FPs’ knowledge of palliative radiotherapy (RT) and referral for palliative RT.

    Authors: Robert A Olson, Sonca Lengoc, Scott Tyldesley, John French, Colleen McGahan and Jenny Soo
    Citation: Radiation Oncology 2012 7:73
  4. Earlier, we showed that in cancer cells, AMP-activated kinase (AMPK) participates in a signal transduction pathway involving ATM-AMPK-p53/p21cip1 which is activated by ionizing radiation (IR) to mediate G2-M arre...

    Authors: Yaryna Storozhuk, Toran Sanli, Sarah N Hopmans, Carrie Schultz, Tom Farrell, Jean-Claude Cutz, Gregory R Steinberg, James Wright, Gurmit Singh and Theodoros Tsakiridis
    Citation: Radiation Oncology 2012 7:71
  5. Quantitative analysis of transcriptional regulation of genes is a prerequisite for a better understanding of the molecular mechanisms of action of different radiation qualities such as photon, proton or carbon...

    Authors: Geeta D Sharungbam, Christian Schwager, Sara Chiblak, Stephan Brons, Lynn Hlatky, Thomas Haberer, Jürgen Debus and Amir Abdollahi
    Citation: Radiation Oncology 2012 7:70
  6. Radiation-induced lung injury (RILI) is an important dose-limiting toxicity during thoracic radiotherapy. The purpose of this study is to investigate single photon emission computed tomography (SPECT) perfusio...

    Authors: Dongqing Wang, Jinbo Sun, Jingyu Zhu, Xiaohong Li, Yanbo Zhen and Songtao Sui
    Citation: Radiation Oncology 2012 7:69
  7. To describe a pilot study for a novel preclinical model used to test human tissue-based therapies in the setting of cutaneous radiation injury.

    Authors: Lucas H Rifkin, Strahinja Stojadinovic, Collin H Stewart, Kwang H Song, Michael C Maxted, Marcus H Bell, Natalie S Kashefi, Michael P Speiser, Michel Saint-Cyr, Michael D Story, Rod J Rohrich, Spencer A Brown and Timothy D Solberg
    Citation: Radiation Oncology 2012 7:68
  8. Androgens stimulate the production of hypoxia-inducible factor (HIF1α) and ultimately vascular endothelial growth factor (VEGF-A). Additionally, epithelial growth factor (EGF) mediates HIF1α production. Carbon...

    Authors: Damien C Weber, Jean-Christophe Tille, Christophe Combescure, Jean-François Egger, Mahomet Laouiti, Karim Hammad, Perrine Granger, Laura Rubbia-Brandt and Raymond Miralbell
    Citation: Radiation Oncology 2012 7:66
  9. To examine the association of polymorphisms in ATM (codon 158), GSTP1 (codon 105), SOD2 (codon 16), TGFB1 (position −509), XPD (codon 751), and XRCC1 (codon 399) with the risk of severe erythema after breast cons...

    Authors: Annette Raabe, Katharina Derda, Sebastian Reuther, Silke Szymczak, Kerstin Borgmann, Ulrike Hoeller, Andreas Ziegler, Cordula Petersen and Ekkehard Dikomey
    Citation: Radiation Oncology 2012 7:65
  10. Cytokines may be elevated in tumor and normal tissues following irradiation. Cytokine expression in these tissues may predict for toxicity or tumor control. The purpose of this pilot study was to determine the...

    Authors: Deborah E Citrin, Ying J Hitchcock, Eun Joo Chung, Jonathan Frandsen, Mary Ellen Urick, William Shield and David Gaffney
    Citation: Radiation Oncology 2012 7:64
  11. Poly (ADP-ribose) polymerase-1 (PARP-1) is a key enzyme involved in the repair of radiation-induced single-strand DNA breaks. PARP inhibitors such as olaparib (KU-0059436, AZD-2281) enhance tumor sensitivity t...

    Authors: Katsutoshi Miura, Koh-ichi Sakata, Masanori Someya, Yoshihisa Matsumoto, Hideki Matsumoto, Akihisa Takahashi and Masato Hareyama
    Citation: Radiation Oncology 2012 7:62
  12. To investigate whether different conditions of DNA structure and radiation treatment could modify heterogeneity of response. Additionally to study variance as a potential parameter of heterogeneity for radiose...

    Authors: Clemens Seidel, Christine Lautenschläger, Jürgen Dunst and Arndt-Christian Müller
    Citation: Radiation Oncology 2012 7:61
  13. Treatment options for oesophageal cancer have changed considerably over the last decades with the introduction of multimodal treatment concepts dominating the progress in the field. However, it remains unclear...

    Authors: Maria C Wolf, Franz Zehentmayr, Michael Schmidt, Dieter Hölzel and Claus Belka
    Citation: Radiation Oncology 2012 7:60
  14. Cancer-Associated Fibroblasts (CAFs) are significant components of solid malignancies and play central roles in cancer sustainability, invasion and metastasis. In this study we have investigated the invasive c...

    Authors: Turid Hellevik, Ingvild Pettersen, Vivian Berg, Jan Olof Winberg, Bjørn T Moe, Kristian Bartnes, Ruth H Paulssen, Lill-Tove Busund, Roy Bremnes, Anthony Chalmers and Iñigo Martinez-Zubiaurre
    Citation: Radiation Oncology 2012 7:59
  15. We report on a case of Waldenström’s macroglobulinemia (WM) treated with splenic re-irradiation. To the best of our knowledge this has not been reported before. A 69-year-old Asian female patient with WM recei...

    Authors: Zhou Wei, Yu Yanxia, Xu Ying, Wang Han and Jiang Yuhua
    Citation: Radiation Oncology 2012 7:58
  16. To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuxima...

    Authors: Alexandra D Jensen, Jürgen Krauss, Karin Potthoff, Christian Simon, Anna V Nikoghosyan, Karen Lossner, Jürgen Debus and Marc W Münter
    Citation: Radiation Oncology 2012 7:57
  17. Intensity-modulated radiotherapy (IMRT) enables a better conformality to the target while sparing the surrounding normal tissues and potentially allows to increase the dose to the target, if this is precisely ...

    Authors: Marcella Palombarini, Stefano Mengoli, Paola Fantazzini, Cecilia Cadioli, Claudio Degli Esposti and Giovanni Piero Frezza
    Citation: Radiation Oncology 2012 7:56
  18. To assess interfraction translational and rotational setup errors, in patients treated with image-guded hypofractionated stereotactic radiotherapy, immobilized by a thermoplastic mask and a bite-block and posi...

    Authors: Gianluca Ingrosso, Roberto Miceli, Dahlia Fedele, Elisabetta Ponti, Michaela Benassi, Rosaria Barbarino, Luana Di Murro, Emilia Giudice, Federico Santarelli and Riccardo Santoni
    Citation: Radiation Oncology 2012 7:54
  19. Brachytherapy as adjuvant treatment for early-stage breast cancer has become widely available and offers patients an expedited treatment schedule. Given this, many women are electing to undergo brachytherapy i...

    Authors: Daniel J Ferraro, Adam A Garsa, Todd A DeWees, Julie A Margenthaler, Michael Naughton, Rebecca Aft, William E Gillanders, Timothy Eberlein, Melissa A Matesa and Imran Zoberi
    Citation: Radiation Oncology 2012 7:53
  20. Histone deacetylase inhibitors are promising new substances in cancer therapy and have also been shown to sensitize different tumor cells to irradiation (XRT). We explored the effect as well as the radiosensit...

    Authors: Markus Thiemann, Susanne Oertel, Volker Ehemann, Wilko Weichert, Albrecht Stenzinger, Marc Bischof, Klaus-J Weber, Ramon Lopez Perez, Uwe Haberkorn, Andreas E Kulozik, Jürgen Debus, Peter E Huber and Claudia Battmann
    Citation: Radiation Oncology 2012 7:52
  21. To investigate repositioning accuracy in particle radiotherapy in 6 degrees of freedom (DOF) and intensity-modulated radiotherapy (IMRT, 3 DOF) for two immobilization devices (Scotchcast masks vs thermoplastic...

    Authors: Alexandra D Jensen, Marcus Winter, Sabine P Kuhn, Jürgen Debus, Olaf Nairz and Marc W Münter
    Citation: Radiation Oncology 2012 7:51
  22. Stereotactic body radiation therapy (SBRT) is a radiation technique used in patients with oligometastatic lung disease. Lung and chest wall toxicities have been described in the patients but pathological verte...

    Authors: María Esperanza Rodríguez-Ruiz, Iñigo San Miguel, Ignacio Gil-Bazo, Jose Luis Perez-Gracia, Leire Arbea, Marta Moreno-Jimenez and Javier Aristu
    Citation: Radiation Oncology 2012 7:50
  23. The radiation field on most megavoltage radiation therapy units are shown by a light field projected through the collimator by a light source mounted inside the collimator. The light field is traditionally use...

    Authors: Christopher F Njeh, Blas Caroprese and Pushkar Desai
    Citation: Radiation Oncology 2012 7:49
  24. The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is activated in tumor cells and promotes tumor cell survival after radiation-induced DNA damage. Because the pathway may not be completely inhibited after b...

    Authors: Emmanouil Fokas, Michio Yoshimura, Remko Prevo, Geoff Higgins, Wolfgang Hackl, Sauveur-Michel Maira, Eric J Bernhard, WGillies McKenna and Ruth J Muschel
    Citation: Radiation Oncology 2012 7:48
  25. Previously, we found that β-galactoside α2,6-sialyltransferase (ST6Gal I), an enzyme that adds sialic acids to N-linked oligosaccharides of glycoproteins and is frequently overexpressed in cancer cells, is up-...

    Authors: Minyoung Lee, Jung-Jin Park, Young-Gyu Ko and Yun-Sil Lee
    Citation: Radiation Oncology 2012 7:47
  26. To evaluate predictive factors for PSA bounce after 125I permanent seed prostate brachytherapy and identify criteria that distinguish between benign bounces and biochemical relapses.

    Authors: Renaud Mazeron, Agathe Bajard, Xavier Montbarbon, Frédéric Gassa, Claude Malet, François Rocher, Sébastien Clippe, Gabriel Bringeon, Olivier Desmettre and Pascal Pommier
    Citation: Radiation Oncology 2012 7:46
  27. To examine the potential improvement in treatment planning for patients with skull base meningioma using IMRT compared to carbon ion or proton beams with and without a gantry.

    Authors: Katsura Kosaki, Swantje Ecker, Daniel Habermehl, Stefan Rieken, Oliver Jäkel, Klaus Herfarth, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:44
  28. The natural history of non-metastatic castrate refractory prostate cancer is unknown and treatment options are limited. We present a retrospective review of 13 patients with locally advanced or high risk prost...

    Authors: Abigail C Pascoe and Santhanam Sundar
    Citation: Radiation Oncology 2012 7:43
  29. Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biological...

    Authors: George Rodrigues, Slav Yartsev, Keng Yeow Tay, Gregory R Pond, Frank Lagerwaard and Glenn Bauman
    Citation: Radiation Oncology 2012 7:42
  30. Particle irradiation was established at the University of Heidelberg 2 years ago. To date, more than 400 patients have been treated including patients with primary brain tumors. In malignant glioma (WHO IV) pa...

    Authors: Stefan Rieken, Daniel Habermehl, Thomas Haberer, Oliver Jaekel, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:41
  31. Total skin electron irradiation (TSEI) is a special radiotherapy technique which has generally been used for treating adult patients with mycosis fungoides. Recently, two infants presented with leukemia cutis ...

    Authors: Qinan Bao, Brian A Hrycushko, Joseph P Dugas, Frederick H Hager and Timothy D Solberg
    Citation: Radiation Oncology 2012 7:40
  32. Histone modifications and DNA methylation are two major factors in epigenetic phenomenon. Unlike the histone deacetylase inhibitors, which are known to exert radiosensitizing effects, there have only been a fe...

    Authors: HakJae Kim, JinHo Kim, EuiKyu Chie, Park DaYoung, InAh Kim and IlHan Kim
    Citation: Radiation Oncology 2012 7:39
  33. We aimed to assess whether gross tumor volume (GTV) determined by fusion of contrast-enhanced computerized tomography (CT) and 18F-fluoro-deoxy-D-glucose positron emission tomography-CT (FDG-PET-CT) based radi...

    Authors: Cem Parlak, Erkan Topkan, Cem Onal, Mehmet Reyhan and Ugur Selek
    Citation: Radiation Oncology 2012 7:37
  34. Complete metastasectomy provides a real chance for long-term survival in patients with oligometastatic colorectal cancer (CRC). For inoperable patients, we evaluated in this study intensity-modulated and image...

    Authors: Benedikt Engels, Thierry Gevaert, Hendrik Everaert, Peter De Coninck, Alexandra Sermeus, Nicolas Christian, Guy Storme, Dirk Verellen and Mark De Ridder
    Citation: Radiation Oncology 2012 7:34
  35. While conventionally fractionated radiation therapy alone is an acceptable option for poor prognostic patients with unresectable stage III NSCLC, we hypothesized that accelerated hypofractionated radiotherapy ...

    Authors: Arya Amini, Steven H Lin, Caimiao Wei, Pamela Allen, James D Cox and Ritsuko Komaki
    Citation: Radiation Oncology 2012 7:33
  36. Consistent delineation of patient anatomy becomes increasingly important with the growing use of highly conformal and adaptive radiotherapy techniques. This study investigates the magnitude and 3D localization...

    Authors: Charlotte L Brouwer, Roel JHM Steenbakkers, Edwin van den Heuvel, Joop C Duppen, Arash Navran, Henk P Bijl, Olga Chouvalova, Fred R Burlage, Harm Meertens, Johannes A Langendijk and Aart A van 't Veld
    Citation: Radiation Oncology 2012 7:32
  37. Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.

    Authors: Pedro J Prada, Lucia Mendez, José Fernández, Herminio González, Isabel Jiménez and Elisabeth Arrojo
    Citation: Radiation Oncology 2012 7:31
  38. Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants particularly attractive for minimal invasive treatment, the pl...

    Authors: Silke B Schwarz, Niklas Thon, Katharina Nikolajek, Maximilian Niyazi, Joerg-Christian Tonn, Claus Belka and Friedrich-Wilhelm Kreth
    Citation: Radiation Oncology 2012 7:30
  39. We retrospectively reviewed magnetic resonance (MR) images of 96 patients with diagnosis of rectal cancer to evaluate tumour stage (T stage), involvement of mesorectal fascia (MRF), and nodal metastasis (N sta...

    Authors: Sabina Giusti, Piero Buccianti, Maura Castagna, Elena Fruzzetti, Silvia Fattori, Elisa Castelluccio, Davide Caramella and Carlo Bartolozzi
    Citation: Radiation Oncology 2012 7:29
  40. To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT).

    Authors: Daniel Habermehl, Kerstin Kessel, Thomas Welzel, Holger Hof, Amir Abdollahi, Frank Bergmann, Stefan Rieken, Jürgen Weitz, Jens Werner, Peter Schirmacher, Markus W Büchler, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:28
  41. We developed a new method for immobilization of the fix lower extremities by using a thermoplastic mask, a carbon fiber base plate, a customized headrest, and an adjustable angle holder. The lower extremities ...

    Authors: Xuhai Zheng, Tangzhi Dai, Xiaochuan Shu, Yuanxue Pu, Gang Feng, Xuesong Li, Dongbiao Liao and Xiaobo Du
    Citation: Radiation Oncology 2012 7:27
  42. Vosaroxin is a first in class naphthyridine analog structurally related to quinolone antibacterials, that intercalates DNA and inhibits topoisomerase II. Vosaroxin is not a P-glycoprotein receptor substrate an...

    Authors: Ira K Gordon, Christian Graves, Whoon J Kil, Tamalee Kramp, Philip Tofilon and Kevin Camphausen
    Citation: Radiation Oncology 2012 7:26

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 132

    Usage 2023
    Downloads: 1,958,690
    Altmetric mentions: 605